{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:05:14Z","timestamp":1788937514558,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41391-025-00999-0","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T15:28:37Z","timestamp":1753198117000},"page":"993-1004","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Head-to-head comparison of diagnostic test accuracy between biparametric and multiparametric MRI: an updated systematic review and bivariate meta-analysis"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2838-6251","authenticated-orcid":false,"given":"Carlos A.","family":"Garcia-Becerra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4433-5345","authenticated-orcid":false,"given":"Maria I.","family":"Arias-Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5027-7540","authenticated-orcid":false,"given":"Jesus E.","family":"Juarez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2634-5427","authenticated-orcid":false,"given":"Veronica","family":"Soltero-Molinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariabelen I.","family":"Rivera-Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Parra-Cama\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Garcia-Becerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9779-1889","authenticated-orcid":false,"given":"Carlos M.","family":"Garc\u00eda-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"999_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, et al. 2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review. Eur Urol. 2023;84:191\u2013206.","journal-title":"Eur Urol"},{"key":"999_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. Epidemiology and Prevention of Prostate Cancer. Eur Urol Oncol. 2021;4:877\u201392.","journal-title":"Eur Urol Oncol"},{"key":"999_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P. Epidemiology of Prostate Cancer. World J Oncol. 2019;10:63\u201389.","journal-title":"World J Oncol"},{"key":"999_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/his.13712","volume":"74","author":"A Matoso","year":"2019","unstructured":"Matoso A, Epstein JI. Defining clinically significant prostate cancer on the basis of pathological findings. Histopathol enero de. 2019;74:135\u201345.","journal-title":"Histopathol enero de"},{"key":"999_CR5","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.juro.2012.07.055","volume":"188","author":"HJ Lavery","year":"2012","unstructured":"Lavery HJ, Droller MJ. Do Gleason patterns 3 and 4 prostate cancer represent separate disease states?. J Urol. 2012;188:1667\u201375.","journal-title":"J Urol"},{"key":"999_CR6","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1158\/0008-5472.CAN-12-2803","volume":"73","author":"IV Kovtun","year":"2013","unstructured":"Kovtun IV, Cheville JC, Murphy SJ, Johnson SH, Zarei S, Kosari F, et al. Lineage relationship of Gleason patterns in Gleason score 7 prostate cancer. Cancer Res. 2013;73:3275\u201384.","journal-title":"Cancer Res"},{"key":"999_CR7","doi-asserted-by":"crossref","unstructured":"Sopyllo K, Erickson AM, Mirtti T. Grading evolution and contemporary prognostic biomarkers of clinically significant prostate cancer. Cancers. 2021;13.","DOI":"10.3390\/cancers13040628"},{"key":"999_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1148\/radiol.10101251","volume":"259","author":"T Franiel","year":"2011","unstructured":"Franiel T, Stephan C, Erbersdobler A, Dietz E, Maxeiner A, Hell N, et al. Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding-multiparametric MR imaging for detection and biopsy planning. Radiol abril de. 2011;259:162\u201372.","journal-title":"Radiol abril de"},{"key":"999_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.juro.2009.10.022","volume":"183","author":"T Hambrock","year":"2010","unstructured":"Hambrock T, Somford DM, Hoeks C, Bouwense SAW, Huisman H, Yakar D, et al. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. J Urol. 2010;183:520\u20137.","journal-title":"J Urol"},{"key":"999_CR10","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1158\/1078-0432.CCR-09-2195","volume":"16","author":"A Sciarra","year":"2010","unstructured":"Sciarra A, Panebianco V, Ciccariello M, Salciccia S, Cattarino S, Lisi D, et al. Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy. Clin Cancer Res J Am Assoc Cancer Res. 2010;16:1875\u201383.","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"key":"999_CR11","doi-asserted-by":"publisher","first-page":"6254","DOI":"10.1158\/1078-0432.CCR-14-0247","volume":"20","author":"TJ Polascik","year":"2014","unstructured":"Polascik TJ, Passoni NM, Villers A, Choyke PL. Modernizing the diagnostic and decision-making pathway for prostate cancer. Clin Cancer Res J Am Assoc Cancer Res. 2014;20:6254\u20137.","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"key":"999_CR12","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet Lond Engl. 2017;389:815\u201322.","journal-title":"Lancet Lond Engl"},{"key":"999_CR13","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, et al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med. 2018;378:1767\u201377.","journal-title":"N Engl J Med"},{"key":"999_CR14","unstructured":"Mottet N, Cornford P, Van Den Bergh RCN, Briers E, De Santis M, Fanti S EAU guidelines on prostate cancer. Update April. 2014."},{"key":"999_CR15","doi-asserted-by":"publisher","first-page":"506","DOI":"10.6004\/jnccn.2019.7306","volume":"17","author":"BR Mason","year":"2019","unstructured":"Mason BR, Eastham JA, Davis BJ, Mynderse LA, Pugh TJ, Lee RJ, et al. Current Status of MRI and PET in the NCCN Guidelines for Prostate Cancer. J Natl Compr Cancer Netw JNCCN. 2019;17:506\u201313.","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"999_CR16","doi-asserted-by":"crossref","unstructured":"De Perrot T, Sadjo Zoua C, Glessgen CG, Botsikas D, Berchtold L, Salomir R, et al. Diffusion-Weighted MRI in the Genitourinary System. J Clin Med.2022;11.","DOI":"10.3390\/jcm11071921"},{"key":"999_CR17","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.2217\/fon.15.206","volume":"11","author":"AG Wibmer","year":"2015","unstructured":"Wibmer AG, Vargas HA, Hricak H. Role of MRI in the diagnosis and management of prostate cancer. Future Oncol Lond Engl. 2015;11:2757\u201366.","journal-title":"Future Oncol Lond Engl"},{"key":"999_CR18","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.2214\/AJR.12.8510","volume":"198","author":"S Verma","year":"2012","unstructured":"Verma S, Turkbey B, Muradyan N, Rajesh A, Cornud F, Haider MA, et al. Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. Am J Roentgenol. 2012;198:1277\u201388.","journal-title":"Am J Roentgenol"},{"key":"999_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","volume":"69","author":"JC Weinreb","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, et al. PI-RADS Prostate Imaging \u2013 Reporting and Data System: 2015, Version 2. Eur Urol. 2016;69:16\u201340.","journal-title":"Eur Urol"},{"key":"999_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4081\/aiua.2022.2.160","volume":"94","author":"N Faccioli","year":"2022","unstructured":"Faccioli N, Santi E, Foti G, Curti P, D\u2019Onofrio M. Cost-effectiveness analysis of short biparametric magnetic resonance imaging protocol in men at risk of prostate cancer. Arch Ital Urol E Androl. 2022;94:160\u20135.","journal-title":"Arch Ital Urol E Androl"},{"key":"999_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.22465\/juo.224400600030","volume":"21","author":"JS Huh","year":"2023","unstructured":"Huh JS, Park KK. A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening. J Urol Oncol. 2023;21:121\u20137.","journal-title":"J Urol Oncol"},{"key":"999_CR22","first-page":"S96","volume":"42","author":"B Pockros","year":"2024","unstructured":"Pockros B, Davenport MS, Stensland K, Sekar R, Morgan T. Prostate Mri Without Contrast: Opportunity To Reduce Financial Toxicity And Improve Access For Patients With Prostate Cancer. Urol Oncol Semin Orig Investig. 2024;42:S96\u20137.","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"999_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41391-019-0158-x","volume":"23","author":"KK Porter","year":"2020","unstructured":"Porter KK, King A, Galgano SJ, Sherrer RL, Gordetsky JB, Rais-Bahrami S. Financial implications of biparametric prostate MRI. Prostate Cancer Prostatic Dis. 2020;23:88\u201393.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"999_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/jmri.25625","volume":"46","author":"TJ Fraum","year":"2017","unstructured":"Fraum TJ, Ludwig DR, Bashir MR, Fowler KJ. Gadolinium-based contrast agents: A comprehensive risk assessment. J Magn Reson Imaging. 2017;46:338\u201353.","journal-title":"J Magn Reson Imaging"},{"key":"999_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1053\/j.ajkd.2020.07.012","volume":"77","author":"MR Rudnick","year":"2021","unstructured":"Rudnick MR, Wahba IM, Leonberg-Yoo AK, Miskulin D, Litt HI. Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review. Am J Kidney Dis J Natl Kidney Found. 2021;77:517\u201328.","journal-title":"Am J Kidney Dis J Natl Kidney Found"},{"key":"999_CR26","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41391-020-00298-w","volume":"24","author":"EJ Bass","year":"2021","unstructured":"Bass EJ, Pantovic A, Connor M, Gabe R, Padhani AR, Rockall A, et al. A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk. Prostate Cancer Prostatic Dis. 2021;24:596\u2013611.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"999_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bju.14759","volume":"124","author":"M Alabousi","year":"2019","unstructured":"Alabousi M, Salameh JP, Gusenbauer K, Samoilov L, Jafri A, Yu H, et al. Biparametric vs multiparametric prostate magnetic resonance imaging for the detection of prostate cancer in treatment-na\u00efve patients: a diagnostic test accuracy systematic review and meta-analysis. BJU Int. 2019;124:209\u201320.","journal-title":"BJU Int"},{"key":"999_CR28","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.","journal-title":"BMJ"},{"key":"999_CR29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/biostatistics\/kxm052","volume":"9","author":"AH Zwinderman","year":"2008","unstructured":"Zwinderman AH, Glas AS, Bossuyt PM, Florie J, Bipat S, Stoker J. Statistical models for quantifying diagnostic accuracy with multiple lesions per patient. Biostatistics. 2008;9:513\u201322.","journal-title":"Biostatistics"},{"key":"999_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.","journal-title":"BMC Med Res Methodol"},{"key":"999_CR31","doi-asserted-by":"crossref","unstructured":"QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies., Annals of Internal Medicine. 2011. Vol. 155 p. 529-36.","DOI":"10.7326\/0003-4819-155-8-201110180-00009"},{"key":"999_CR32","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","volume":"58","author":"JB Reitsma","year":"2005","unstructured":"Reitsma JB, Glas AS, Rutjes AWS, Scholten RJPM, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58:982\u201390.","journal-title":"J Clin Epidemiol"},{"key":"999_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3102\/10769986030003261","volume":"30","author":"W Viechtbauer","year":"2005","unstructured":"Viechtbauer W. Bias and Efficiency of Meta-Analytic Variance Estimators in the Random-Effects Model. J Educ Behav Stat. 2005;30:261\u201393.","journal-title":"J Educ Behav Stat"},{"key":"999_CR34","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1080\/03610918.2018.1489553","volume":"49","author":"H Holling","year":"2020","unstructured":"Holling H, B\u00f6hning W, Masoudi E, B\u00f6hning D, Sangnawakij P. Evaluation of a new version of I2 with emphasis on diagnostic problems. Commun Stat-Simul Comput. 2020;49:942\u201372.","journal-title":"Commun Stat-Simul Comput"},{"key":"999_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2214\/AJR.06.0226","volume":"187","author":"C Gatsonis","year":"2006","unstructured":"Gatsonis C, Paliwal P. Meta-Analysis of Diagnostic and Screening Test Accuracy Evaluations: Methodologic Primer. Am J Roentgenol. 2006;187:271\u201381.","journal-title":"Am J Roentgenol"},{"key":"999_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","volume":"28","author":"R DerSimonian","year":"2007","unstructured":"DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28:105\u201314.","journal-title":"Contemp Clin Trials"},{"key":"999_CR37","doi-asserted-by":"crossref","unstructured":"Ost DE Interpretation and Application of the Likelihood Ratio to Clinical Practice in Thoracic Oncology. J Bronchol Interv Pulmonol [Internet]. 2022;29. Disponible en: https:\/\/journals.lww.com\/bronchology\/fulltext\/2022\/01000\/interpretation_and_application_of_the_likelihood.10.aspx","DOI":"10.1097\/LBR.0000000000000788"},{"key":"999_CR38","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","volume":"56","author":"AS Glas","year":"2003","unstructured":"Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PMM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56:1129\u201335.","journal-title":"J Clin Epidemiol"},{"key":"999_CR39","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/bju.14640","volume":"123","author":"M Assel","year":"2019","unstructured":"Assel M, Sjoberg D, Elders A, Wang X, Huo D, Botchway A, et al. Guidelines for reporting of statistics for clinical research in urology. BJU Int. 2019;123:401\u201310.","journal-title":"BJU Int"},{"key":"999_CR40","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.chest.2019.10.064","volume":"158","author":"MW Kattan","year":"2020","unstructured":"Kattan MW, Vickers AJ. Statistical Analysis and Reporting Guidelines for CHEST. CHEST. 2020;158:S3\u201311.","journal-title":"CHEST"},{"key":"999_CR41","doi-asserted-by":"publisher","first-page":"e0128804","DOI":"10.1371\/journal.pone.0128804","volume":"10","author":"S Donegan","year":"2015","unstructured":"Donegan S, Williams L, Dias S, Tudur-Smith C, Welton N. Exploring treatment by covariate interactions using subgroup analysis and meta-regression in cochrane reviews: a review of recent practice. PloS One. 2015;10:e0128804.","journal-title":"PloS One"},{"key":"999_CR42","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jclinepi.2009.02.002","volume":"62","author":"TH Hamza","year":"2009","unstructured":"Hamza TH, van Houwelingen HC, Heijenbrok-Kal MH, Stijnen T. Associating explanatory variables with summary receiver operating characteristic curves in diagnostic meta-analysis. J Clin Epidemiol. 2009;62:1284\u201391.","journal-title":"J Clin Epidemiol"},{"key":"999_CR43","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ciresp.2024.03.006","volume":"102","author":"J S\u00e1nchez-Meca","year":"2024","unstructured":"S\u00e1nchez-Meca J, Botella J. Moderators analysis in meta-analysis: Meta-regression and subgroups analyzes. Cirugia Espanola. 2024;102:446\u20137.","journal-title":"Cirugia Espanola"},{"key":"999_CR44","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.euo.2021.03.007","volume":"4","author":"F Russo","year":"2021","unstructured":"Russo F, Mazzetti S, Regge D, Ambrosini I, Giannini V, Manfredi M, et al. Diagnostic accuracy of single-plane biparametric and multiparametric magnetic resonance imaging in prostate cancer: a randomized noninferiority trial in Biopsy-na\u00efve Men. Eur Urol Oncol. 2021;4:855\u201362.","journal-title":"Eur Urol Oncol"},{"key":"999_CR45","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1007\/s00345-022-04120-1","volume":"40","author":"WM Thaiss","year":"2022","unstructured":"Thaiss WM, Moser S, Hepp T, Kruck S, Rausch S, Scharpf M, et al. Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy. World J Urol. 2022;40:2431\u20138.","journal-title":"World J Urol"},{"key":"999_CR46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1148\/radiol.2017170129","volume":"285","author":"CK Kuhl","year":"2017","unstructured":"Kuhl CK, Bruhn R, Kr\u00e4mer N, Nebelung S, Heidenreich A, Schrading S. Abbreviated biparametric prostate MR imaging in men with elevated prostate-specific antigen. Radiology. 2017;285:493\u2013505.","journal-title":"Radiology"},{"key":"999_CR47","doi-asserted-by":"crossref","unstructured":"Pesapane F, Acquasanta M, Meo RD, Agazzi GM, Tantrige P, Codari M, et al. Comparison of sensitivity and specificity of biparametric versus multiparametric prostate MRI in the detection of prostate cancer in 431 men with elevated prostate-specific antigen levels. Diagnostics. 2021;11.","DOI":"10.3390\/diagnostics11071223"},{"key":"999_CR48","doi-asserted-by":"crossref","unstructured":"Brembilla G, Giganti F, Sidhu H, Imbriaco M, Mallett S, Stabile A, et al. Diagnostic accuracy of abbreviated bi-parametric MRI (a-bpMRI) for prostate cancer detection and screening: a multi-reader study. Diagnostics. 2022;12.","DOI":"10.3390\/diagnostics12020231"},{"key":"999_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-019-0274-9","volume":"19","author":"L Xu","year":"2019","unstructured":"Xu L, Zhang G, Shi B, Liu Y, Zou T, Yan W, et al. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer. Cancer Imaging. 2019;19:90.","journal-title":"Cancer Imaging"},{"key":"999_CR50","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1007\/s00330-020-06782-0","volume":"30","author":"JP Zawaideh","year":"2020","unstructured":"Zawaideh JP, Sala E, Shaida N, Koo B, Warren AY, Carmisciano L, et al. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice. Eur Radio. 2020;30:4039\u201349.","journal-title":"Eur Radio"},{"key":"999_CR51","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.eururo.2019.05.029","volume":"76","author":"M van der Leest","year":"2019","unstructured":"van der Leest M, Isra\u00ebl B, Cornel EB, Z\u00e1mecnik P, Schoots IG, van der Lelij H, et al. High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-na\u00efve Men: The Next Step in Magnetic Resonance Imaging Accessibility. Eur Urol. 2019;76:574\u201381.","journal-title":"Eur Urol"},{"key":"999_CR52","doi-asserted-by":"publisher","first-page":"205846011666304","DOI":"10.1177\/2058460116663046","volume":"5","author":"KCD Thestrup","year":"2016","unstructured":"Thestrup KCD, Logager V, Baslev I, M\u00f8ller JM, Hansen RH, Thomsen HS. Biparametric versus multiparametric MRI in the diagnosis of prostate cancer. Acta Radio Open. 2016;5:2058460116663046.","journal-title":"Acta Radio Open"},{"key":"999_CR53","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1007\/s00261-022-03553-x","volume":"47","author":"J Zhang","year":"2022","unstructured":"Zhang J, Xu L, Zhang G, Zhang X, Bai X, Ji Z, et al. Comparison between biparametric and multiparametric MRI diagnosis strategy for prostate cancer in the peripheral zone using PI-RADS version 2.1. Abdom Radio. 2022;47:2905\u201316.","journal-title":"Abdom Radio"},{"key":"999_CR54","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.4103\/jcrt.JCRT_1313_20","volume":"18","author":"M Mahajan","year":"2022","unstructured":"Mahajan M, Gupta V, Gupta P, Sharma P, Abrol D. Evaluation of clinically significant prostate cancer using biparametric magnetic resonance imaging: An evolving concept. J Cancer Res Ther. 2022;18:1640\u20135.","journal-title":"J Cancer Res Ther"},{"key":"999_CR55","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jmri.27283","volume":"53","author":"T Tamada","year":"2021","unstructured":"Tamada T, Kido A, Yamamoto A, Takeuchi M, Miyaji Y, Moriya T, et al. Comparison of biparametric and multiparametric MRI for clinically significant prostate cancer detection with PI-RADS Version 2.1. J Magn Reson Imaging. 2021;53:283\u201391.","journal-title":"J Magn Reson Imaging"},{"key":"999_CR56","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/jmri.27394","volume":"53","author":"J Bao","year":"2021","unstructured":"Bao J, Zhi R, Hou Y, Zhang J, Wu CJ, Wang XM, et al. Optimized MRI assessment for clinically significant prostate cancer: A STARD-compliant two-center study. J Magn Reson Imaging. 2021;53:1210\u20139.","journal-title":"J Magn Reson Imaging"},{"key":"999_CR57","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2214\/AJR.18.20498","volume":"212","author":"MH Choi","year":"2019","unstructured":"Choi MH, Kim CK, Lee YJ, Jung SE. Prebiopsy biparametric MRI for clinically significant prostate cancer detection with PI-RADS Version 2: A multicenter study. Am J Roentgenol. 2019;212:839\u201346.","journal-title":"Am J Roentgenol"},{"key":"999_CR58","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s00261-019-01934-3","volume":"44","author":"M Gatti","year":"2019","unstructured":"Gatti M, Faletti R, Calleris G, Giglio J, Berzovini C, Gentile F, et al. Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI). Abdom Radio. 2019;44:1883\u201393.","journal-title":"Abdom Radio"},{"key":"999_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.crad.2016.09.011","volume":"72","author":"P De Visschere","year":"2017","unstructured":"De Visschere P, Lumen N, Ost P, Decaestecker K, Pattyn E, Villeirs G. Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. Clin Radio. 2017;72:23\u201332.","journal-title":"Clin Radio"},{"key":"999_CR60","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1148\/radiol.2017162020","volume":"284","author":"BK Barth","year":"2017","unstructured":"Barth BK, De Visschere PJL, Cornelius A, Nicolau C, Vargas HA, Eberli D, et al. Detection of clinically significant prostate cancer: short dual\u2013pulse sequence versus standard multiparametric MR Imaging\u2014A multireader study. Radiology. 2017;284:725\u201336.","journal-title":"Radiology"},{"key":"999_CR61","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/pcan.2015.29","volume":"18","author":"JP Radtke","year":"2015","unstructured":"Radtke JP, Boxler S, Kuru TH, Wolf MB, Alt CD, Popeneciu IV, et al. Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance. Prostate Cancer Prostat Dis. 2015;18:288\u201396.","journal-title":"Prostate Cancer Prostat Dis"},{"key":"999_CR62","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/bju.14538","volume":"123","author":"S Van Nieuwenhove","year":"2019","unstructured":"Van Nieuwenhove S, Saussez TP, Thiry S, Trefois P, Annet L, Michoux N, et al. Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer. BJU Int. 2019;123:411\u201320.","journal-title":"BJU Int"},{"key":"999_CR63","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2214\/AJR.20.23219","volume":"216","author":"R Cuocolo","year":"2021","unstructured":"Cuocolo R, Verde F, Ponsiglione A, Romeo V, Petretta M, Imbriaco M, et al. Clinically significant prostate cancer detection with biparametric MRI: A systematic review and meta-analysis. Am J Roentgenol. 2021;216:608\u201321.","journal-title":"Am J Roentgenol"},{"key":"999_CR64","doi-asserted-by":"publisher","first-page":"e070280","DOI":"10.1136\/bmjopen-2022-070280","volume":"13","author":"A Asif","year":"2023","unstructured":"Asif A, Nathan A, Ng A, Khetrapal P, Chan VWS, Giganti F, et al. Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol. BMJ Open. 2023;13:e070280.","journal-title":"BMJ Open"},{"key":"999_CR65","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.2146\/ajhp040558","volume":"62","author":"L Wen","year":"2005","unstructured":"Wen L, Badgett R,Cornell J.Number needed to treat: A descriptor for weighing therapeutic options.Am J Health Syst Pharm.2005;62:2031\u20136.","journal-title":"Am J Health Syst Pharm"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00999-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00999-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00999-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:06:49Z","timestamp":1764047209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-00999-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["999"],"URL":"https:\/\/doi.org\/10.1038\/s41391-025-00999-0","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study did not involve the direct participation of human subjects; thus, an informed consent was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}